Document
type: Class

4769159
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: http://irises.unisr.it/resource/item/88563

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

individual
rights: termsOfUse
date: 2026-08-24T07:15:08
publisher: http://irises.unisr.it/resource/item/88563
type: Document
label: RDF description of Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial - http://irises.unisr.it/resource/item/88563

http://irises.unisr.it/resource/item/88563
type: Continuant
most specific type: Academic Article
type: Generically Dependent Continuant
related by: 4769159
type: Document
label: Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
type: Information Content Entity
type: Thing
type: Entity
type: Article
language: Inglese
type: Academic Article

Generically Dependent Continuant
type: Class

Article
type: Class

Inglese
type: Language

Information Content Entity
type: Class